
Overview
The Seattle Alzheimer's Disease Brain Cell Atlas (SEA-AD) study provides transcriptomic and chromatin accessibility data from single nuclei isolated from postmortem brain tissue from individuals spanning the Alzheimer's disease spectrum. The study supports investigation of cellular and molecular changes associated with Alzheimer's disease progression and includes data generated as part of the broader SEA-AD effort to characterize brain cell types, disease-associated cellular states, and related neuropathology.
Features and programs
Open Data Sponsorship Program
Pricing
This is a publicly available data set. No subscription is required.
How can we make this page better?
Legal
Content disclaimer
Delivery details
AWS Data Exchange (ADX)
AWS Data Exchange is a service that helps AWS easily share and manage data entitlements from other organizations at scale.
Open data resources
Available with or without an AWS account.
- How to use
- To access these resources, reference the Amazon Resource Name (ARN) using the AWS Command Line Interface (CLI). Learn more
- Description
- This study provides transcriptomic and chromatin accessibility data from single nuclei isolated from brain tissue of 84 aged individuals spanning the full spectrum of Alzheimer's disease severity and 5 neurotypical adult reference individuals, as well as genotype data for those individuals.
- Resource type
- S3 bucket
- Amazon Resource Name (ARN)
- arn:aws:s3:::sea-ad.opendata.sagebase.org
- AWS region
- us-east-1
- AWS CLI access (No AWS account required)
- aws s3 ls --no-sign-request s3://sea-ad.opendata.sagebase.org/
Resources
Vendor resources
Support
Managed By
Sage Bionetworks
How to cite
Seattle Alzheimer's Disease Brain Cell Atlas (SEA-AD) Raw Data was accessed on DATE from https://registry.opendata.aws/sage-sea-ad-atlas .
Similar products


